Literature DB >> 31245070

Surgery for stage IIIA-N2 non-small cell lung cancer: the jury is still out!

Lawek Berzenji1, Paul Beckers1, Paul E Van Schil1.   

Abstract

Entities:  

Year:  2019        PMID： 31245070      PMCID： PMC6560604          DOI： 10.21037/jtd.2019.04.36

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  25 in total

Review 1.  Outcome of surgery versus radiotherapy after induction treatment in patients with N2 disease: systematic review and meta-analysis of randomised trials.

Authors:  P J McElnay; A Choong; E Jordan; F Song; E Lim
Journal:  Thorax       Date:  2015-05-12       Impact factor: 9.139

2.  Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.

Authors:  Jan P van Meerbeeck; Gijs W P M Kramer; Paul E Y Van Schil; Catherine Legrand; Egbert F Smit; Franz Schramel; Vivianne C Tjan-Heijnen; Bonne Biesma; Channa Debruyne; Nico van Zandwijk; Ted A W Splinter; Giuseppe Giaccone
Journal:  J Natl Cancer Inst       Date:  2007-03-21       Impact factor: 13.506

Review 3.  2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.

Authors:  W E E Eberhardt; D De Ruysscher; W Weder; C Le Péchoux; P De Leyn; H Hoffmann; V Westeel; R Stahel; E Felip; S Peters
Journal:  Ann Oncol       Date:  2015-04-20       Impact factor: 32.976

4.  Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.

Authors:  Giorgio V Scagliotti; Ugo Pastorino; Johan F Vansteenkiste; Lorenzo Spaggiari; Francesco Facciolo; Tadeusz M Orlowski; Luigi Maiorino; Martin Hetzel; Monika Leschinger; Carla Visseren-Grul; Valter Torri
Journal:  J Clin Oncol       Date:  2011-11-28       Impact factor: 44.544

Review 5.  Concurrent chemoradiotherapy in non-small cell lung cancer.

Authors:  Noelle O'Rourke; Marta Roqué I Figuls; Nuria Farré Bernadó; Fergus Macbeth
Journal:  Cochrane Database Syst Rev       Date:  2010-06-16

6.  Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer.

Authors:  Alain Depierre; Bernard Milleron; Denis Moro-Sibilot; Sylvie Chevret; Elisabeth Quoix; Bernard Lebeau; Denis Braun; Jean-Luc Breton; Etienne Lemarié; Sylvie Gouva; Nadine Paillot; Jeanne-Marie Bréchot; Henri Janicot; François-Xavier Lebas; Philippe Terrioux; Jean Clavier; Pascal Foucher; Michel Monchâtre; Daniel Coëtmeur; Marie-Claude Level; Pascal Leclerc; François Blanchon; Jean-Michel Rodier; Luc Thiberville; Anne Villeneuve; Virginie Westeel; Claude Chastang
Journal:  J Clin Oncol       Date:  2002-01-01       Impact factor: 44.544

7.  Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.

Authors:  Kathy S Albain; R Suzanne Swann; Valerie W Rusch; Andrew T Turrisi; Frances A Shepherd; Colum Smith; Yuhchyau Chen; Robert B Livingston; Richard H Feins; David R Gandara; Willard A Fry; Gail Darling; David H Johnson; Mark R Green; Robert C Miller; Joanne Ley; Willliam T Sause; James D Cox
Journal:  Lancet       Date:  2009-07-24       Impact factor: 79.321

8.  Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.

Authors:  Nael Al-Sarraf; Rashid Aziz; Kathy Gately; Julie Lucey; Lorraine Wilson; Eillish McGovern; Vincent Young
Journal:  Eur J Cardiothorac Surg       Date:  2007-10-30       Impact factor: 4.191

9.  Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer.

Authors:  Paul C Lee; Jeffrey L Port; Robert J Korst; Yaakov Liss; Danish N Meherally; Nasser K Altorki
Journal:  Ann Thorac Surg       Date:  2007-07       Impact factor: 4.330

Review 10.  Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review.

Authors:  David Gilligan; Marianne Nicolson; Ian Smith; Harry Groen; Otilia Dalesio; Peter Goldstraw; Matthew Hatton; Penelope Hopwood; Christian Manegold; Franz Schramel; Hans Smit; Jan van Meerbeeck; Matthew Nankivell; Mahesh Parmar; Cheryl Pugh; Richard Stephens
Journal:  Lancet       Date:  2007-06-09       Impact factor: 79.321
View more
  1 in total

1.  Evaluation of mediastinoscopy in mediastinal lymph node staging for non-small-cell lung cancer.

Authors:  Ian Diebels; Jeroen M H Hendriks; Jan P Van Meerbeeck; Patrick Lauwers; Annelies Janssens; Suresh K Yogeswaran; Paul E Y Van Schil
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-01-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.